Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IBM's Watson Group signs up genomics partners

Nature Biotechnology volume 33, pages 10–11 (2015)Cite this article

Subjects

Of the 3,700 companies that have approached IBM Watson to ask about building on top of its technology, 30% are from the healthcare field.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Boca Raton, Florida

    Mark Ratner

Authors
  1. Mark Ratner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ratner, M. IBM's Watson Group signs up genomics partners. Nat Biotechnol 33, 10–11 (2015). https://doi.org/10.1038/nbt0115-10

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0115-10

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research